Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

J.A. Maldjian; C.T. Whitlow

doi:10.3174/ajnr.A3113

Research ArticleFunctional

Open Access

Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

J.A. Maldjian and C.T. Whitlow for the Alzheimer's Disease Neuroimaging Initiative

American Journal of Neuroradiology November 2012, 33 (10) 1975-1982; DOI: https://doi.org/10.3174/ajnr.A3113

J.A. Maldjian

aFrom the Department of Radiology (J.A.M., C.T.W.)

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

C.T. Whitlow

aFrom the Department of Radiology (J.A.M., C.T.W.)

bTranslational Science Institute (C.T.W.), Wake Forest School of Medicine, Winston-Salem, North Carolina.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
Responses
References
PDF

Article Information

vol. 33 no. 10 1975-1982

DOI

https://doi.org/10.3174/ajnr.A3113

PubMed

22700745

Published By

American Journal of Neuroradiology

Print ISSN

0195-6108

Online ISSN

1936-959X

History

Received January 31, 2012
Accepted after revision February 20, 2012
Published online November 15, 2012.

Author Information

J.A. Maldjiana and
C.T. Whitlowa,b
for the Alzheimer's Disease Neuroimaging Initiative*

^aFrom the Department of Radiology (J.A.M., C.T.W.)
^bTranslational Science Institute (C.T.W.), Wake Forest School of Medicine, Winston-Salem, North Carolina.

Please address correspondence to Joseph Maldjian, MD, Department of Radiology, Wake Forest University Health Sciences, Winston-Salem, NC 27157; e-mail: maldjian{at}wakehealth.edu

View Full Text

Altmetrics

Cited By...

16 Citations
19 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound

Nir Lipsman, Ying Meng, Allison J. Bethune, Yuexi Huang, Benjamin Lam, Mario Masellis, Nathan Herrmann, Chinthaka Heyn, Isabelle Aubert, Alexandre Boutet, Gwenn S. Smith, Kullervo Hynynen, Sandra E. Black

Nature Communications 2018 9 1
Brain fluorodeoxyglucose (FDG) PET in dementia

Takashi Kato, Yoshitaka Inui, Akinori Nakamura, Kengo Ito

Ageing Research Reviews 2016 30
PET Approaches for Diagnosis of Dementia

K. Ishii

American Journal of Neuroradiology 2014 35 11
In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease

Tatsuhiro Terada, Tomokazu Obi, Tomoyasu Bunai, Takashi Matsudaira, Etsuji Yoshikawa, Ichiro Ando, Masami Futatsubashi, Hideo Tsukada, Yasuomi Ouchi

Neurology 2020 94 15
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia

Esther E. Bron, Rebecca M.E. Steketee, Gavin C. Houston, Ruth A. Oliver, Hakim C. Achterberg, Marco Loog, John C. van Swieten, Alexander Hammers, Wiro J. Niessen, Marion Smits, Stefan Klein

Human Brain Mapping 2014 35 9
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Valentina Garibotto, Karl Herholz, Marina Boccardi, Agnese Picco, Andrea Varrone, Agneta Nordberg, Flavio Nobili, Osman Ratib

Neurobiology of Aging 2017 52
The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats

Jae-Hyung Park, Jeong-Ho Hong, Sang-Woo Lee, Hyun Dong Ji, Jung-Ah Jung, Kyung-Wha Yoon, Jung-In Lee, Kyoung Sook Won, Bong-Il Song, Hae Won Kim

Scientific Reports 2019 9 1
Regional Correlation between Resting State FDG PET and pCASL Perfusion MRI

Yoon-Hee K Cha, Mayank A Jog, Yoon-Chung Kim, Shruthi Chakrapani, Stephen M Kraman, Danny JJ Wang

Journal of Cerebral Blood Flow & Metabolism 2013 33 12
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI

Val J. Lowe, Patrick J. Peller, Stephen D. Weigand, Catalina Montoya Quintero, Nirubol Tosakulwong, Prashanthi Vemuri, Matthew L. Senjem, Lennon Jordan, Clifford R. Jack, David Knopman, Ronald C. Petersen

Neurology 2013 80 23
The value of whole-brain CT perfusion imaging and CT angiography using a 320-slice CT scanner in the diagnosis of MCI and AD patients

Bo Zhang, Guo-jun Gu, Hong Jiang, Yi Guo, Xing Shen, Bo Li, Wei Zhang

European Radiology 2017 27 11
Regional uptakes from early-frame amyloid PET and 18F-FDG PET scans are comparable independent of disease state

Alison Myoraku, Gregory Klein, Susan Landau, Duygu Tosun

European Journal of Hybrid Imaging 2022 6 1
Image segmentation and registration algorithm to collect thoracic skeleton semilandmarks for characterization of age and sex-based thoracic morphology variation

Ashley A. Weaver, Callistus M. Nguyen, Samantha L. Schoell, Joseph A. Maldjian, Joel D. Stitzel

Computers in Biology and Medicine 2015 67
Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer’s Type

Charles B. Malpas, Michael M. Saling, Dennis Velakoulis, Patricia Desmond, Rodney J. Hicks, Henrik Zetterberg, Kaj Blennow, Terence J. O’Brien, Joel Ramirez

Journal of Alzheimer’s Disease 2018 62 1
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia

Charis Styliadis, Panagiotis Kartsidis, Evangelos Paraskevopoulos

2015
Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy

Jiajie Mo, Yao Wang, Jianguo Zhang, Lixin Cai, Qingzhu Liu, Wenhan Hu, Lin Sang, Chao Zhang, Xiu Wang, Xiaoqiu Shao, Kai Zhang

EJNMMI Research 2022 12 1
PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use

Freimut Juengling, Frank Wuest, Ralf Schirrmacher, Jonathan Abele, Alexander Thiel, Jean-Paul Soucy, Richard Camicioli, Valentina Garibotto

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2025 52 1
Identification and validation of a gray matter volume network in Alzheimer's disease

Munkhzaya Chuluunbat, Daiki Matsuda, Koji Fujita, Maki Otomo, Yoichi Otomi, Kohsuke Kudo, Masafumi Harada, Yushin Izumi

Journal of the Neurological Sciences 2022 440
Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer’s disease

Lars Frings, Ganna Blazhenets, Joachim Brumberg, Alexander Rau, Horst Urbach, Philipp T. Meyer

Scientific Reports 2024 14 1
Medical Imaging

Charis Styliadis, Panagiotis Kartsidis, Evangelos Paraskevopoulos

2017

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 33, Issue 10

1 Nov 2012

Table of Contents
Index by author

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

J.A. Maldjian, C.T. Whitlow

Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

American Journal of Neuroradiology Nov 2012, 33 (10) 1975-1982; DOI: 10.3174/ajnr.A3113

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

J.A. Maldjian, C.T. Whitlow

American Journal of Neuroradiology Nov 2012, 33 (10) 1975-1982; DOI: 10.3174/ajnr.A3113

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
Responses
References
PDF

PubMed
Google Scholar

Cited By...

In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease
CSF biomarkers are differentially related to structural and functional changes in dementia of the Alzheimers type
PET Approaches for Diagnosis of Dementia
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI

Crossref (19)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound

Nir Lipsman, Ying Meng, Allison J. Bethune, Yuexi Huang, Benjamin Lam, Mario Masellis, Nathan Herrmann, Chinthaka Heyn, Isabelle Aubert, Alexandre Boutet, Gwenn S. Smith, Kullervo Hynynen, Sandra E. Black

Nature Communications 2018 9 1
Brain fluorodeoxyglucose (FDG) PET in dementia

Takashi Kato, Yoshitaka Inui, Akinori Nakamura, Kengo Ito

Ageing Research Reviews 2016 30
PET Approaches for Diagnosis of Dementia

K. Ishii

American Journal of Neuroradiology 2014 35 11
In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease

Tatsuhiro Terada, Tomokazu Obi, Tomoyasu Bunai, Takashi Matsudaira, Etsuji Yoshikawa, Ichiro Ando, Masami Futatsubashi, Hideo Tsukada, Yasuomi Ouchi

Neurology 2020 94 15
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia

Esther E. Bron, Rebecca M.E. Steketee, Gavin C. Houston, Ruth A. Oliver, Hakim C. Achterberg, Marco Loog, John C. van Swieten, Alexander Hammers, Wiro J. Niessen, Marion Smits, Stefan Klein

Human Brain Mapping 2014 35 9
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Valentina Garibotto, Karl Herholz, Marina Boccardi, Agnese Picco, Andrea Varrone, Agneta Nordberg, Flavio Nobili, Osman Ratib

Neurobiology of Aging 2017 52
The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer's disease: A positron emission tomography study in rats

Jae-Hyung Park, Jeong-Ho Hong, Sang-Woo Lee, Hyun Dong Ji, Jung-Ah Jung, Kyung-Wha Yoon, Jung-In Lee, Kyoung Sook Won, Bong-Il Song, Hae Won Kim

Scientific Reports 2019 9 1
Regional Correlation between Resting State FDG PET and pCASL Perfusion MRI

Yoon-Hee K Cha, Mayank A Jog, Yoon-Chung Kim, Shruthi Chakrapani, Stephen M Kraman, Danny JJ Wang

Journal of Cerebral Blood Flow & Metabolism 2013 33 12
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI

Val J. Lowe, Patrick J. Peller, Stephen D. Weigand, Catalina Montoya Quintero, Nirubol Tosakulwong, Prashanthi Vemuri, Matthew L. Senjem, Lennon Jordan, Clifford R. Jack, David Knopman, Ronald C. Petersen

Neurology 2013 80 23
The value of whole-brain CT perfusion imaging and CT angiography using a 320-slice CT scanner in the diagnosis of MCI and AD patients

Bo Zhang, Guo-jun Gu, Hong Jiang, Yi Guo, Xing Shen, Bo Li, Wei Zhang

European Radiology 2017 27 11

Main menu

User menu

Search

American Journal of Neuroradiology

Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited

Article Information

Author Information

Altmetrics

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Indexed Content

Cases

Special Collections

Resources

Multimedia

About Us

American Society of Neuroradiology